Indication
Severe Eosinophilic Asthma with or without CRSwNP
1 clinical trial
1 product
Clinical trial
Role of Epithelial Barrier Integrity in Biologic Treatment Response of Severe Asthmatics With/Out Chronic Rhinosinusitis With Nasal Polyps (CRSwNP). Can Shedding of Epithelial Barrier Proteins be Used as Biomarker in Severe Asthma With/Out CRSwNP Management?Status: Recruiting, Estimated PCD: 2025-05-15
Product
Mepolizumab